Home / Company / Strategic Advisors

Strategic Advisors

Invectys’ Board of Directors and Managers are accompanied by top strategic advisors, experienced in both biotech entrepreneurship and management:

David Epstein, MBA, Chief Strategic Advisor

_
Currently chairman of 4 organizations’ boards, member of 3 additional boards and executive partner at Flagship Pioneering, David brings his vast managing experience to advise the Invectys team. His teams have developed and launched more than 30 new medicines globally.

Professional profile

Pablo Cagnoni, M.D., Strategic Advisor

_
President & CEO of Rubius Therapeutics; Board of Directors member for Fusion Pharmaceuticals, Laronde, Repertoire Immune Medicines and Synthekine. Former President & CEO of Tizona Therapeutics (2015-2018), former CEO of Onyx Therapeutics. played a key role in the development, approval and commercialization of more than 20 life-changing treatments, including Afinitor®, Kyprolis® and Tarceva®.

Professional profile